Remote monitoring of patients with implantable cardioverter defibrillators (ICD): A cute gimmick or an essential tool for clinical excellence?

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 7, 2014, Pages 771-773

  Freedberg, Nahum A ^a   Feldman, Alexander ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

Author keywords

heart failure; ICD shocks; implantable cardioverter defibrillator; remote monitoring; ventricular tachycardia

Indexed keywords

ACUTE HEART FAILURE; ALGORITHM; ARTIFICIAL HEART PACEMAKER; BATTERY DEPLETION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CONVULSIVE THERAPY; COST BENEFIT ANALYSIS; EDITORIAL; ELECTRIC BATTERY; ELECTRONIC MEDICAL RECORD; FOLLOW UP; HEALTH MAINTENANCE ORGANIZATION; HEART ATRIUM ARRHYTHMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOME MONITORING; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEAD MALFUNCTION; LEGAL LIABILITY; MEDICAL DEVICE COMPLICATION; PATIENT COMPLIANCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REIMBURSEMENT; REMOTE SENSING; SUDDEN CARDIAC DEATH; SURVIVAL; WEB BROWSER; ADVERSE EFFECTS; ARRHYTHMIAS, CARDIAC; FEMALE; MALE;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE;

EID: 84904444077     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12415     Document Type: Editorial

References (41)

1. Mirowski M, Reid P, Mower M, Watkins L, Gott V, Schauble J, Langer A, Heilman M, Kolenik S, Fischell R, Weisfeldt M,: Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303: 322-324.
2. Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, Hayes DL, Howlett JG, Kautzner J, Love CJ, Morgan JM, Priori SG, Reynolds DW, Schoenfeld MH, Vardas PE,: HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): Description of techniques, indications, personnel, frequency and ethical considerations: Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace 2008; 10: 707-725.
3. Boriani G, Auricchio A, Klersy C, Kirchhof P, Brugada J, Morgan J, Vardas P,: Healthcare personnel resource burden related to in-clinic follow-up of cardiovascular implantable electronic devices: A European Heart Rhythm Association and Eucomed joint survey. Europace 2011; 13: 1166-1173.
4. Guedon-Moreau L, Mabo P, Kacet S,: Current clinical evidence for remote patient management. Europace 2013; 15: i6-i10.
5. Ricci RP, Morichelli L, Quarta L, Sassi A, Porfili A, Laudadio MT, Gargaro A, Santini M,: Long-term patient acceptance of and satisfaction with implanted device remote monitoring. Europace 2010; 12: 674-679.
6. Ricci RP, Morichelli L, D'Onofrio A, Calo L, Vaccari D, Zanotto G, Curnis A, Buja G, Rovai N, Gargaro A,: Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: The HomeGuide Registry. Europace 2013; 15: 970-977.
7. Hindricks G, Elsner C, Piorkowski C, Taborsky M, Geller JC, Schumacher B, Bytesnik J, Kottkamp H,: Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: Results of the REFORM trial. Eur Heart J 2014; 35: 98-105.
8. Burri H, Sticherling C, Wright D, Makino K, Smala A, Tilden D,: Cost-consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK. Europace 2013; 15: 1601-1608.
9. Kacet S, Guedon-Moreau LG, Lacroix DL, Sadoul NS, Clementy JC, Kouakam CK, Hermida JSH, Aliot EA, on behalf of ECOST: Costs of remote monitoring versus ambulatory follow-up of implanted cardioverter defibrillators in the randomized ECOST study. Eur Heart J 2013; 34: P1391.
10. Varma N, Michalski J, Epstein AE, Schweikert R,: Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: The Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) Trial. Circ Arrhythm Electrophysiol 2010; 3: 428-436.
11. Spencker S, Coban N, Koch L, Schirdewan A, Muller D,: Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace 2009; 11: 483-488.
12. Powell B, Asirvatham S, Perschbacher D, Jones P, Cha Y, Cesario D, Cao M, Gilliam F, Saxon L,: Noise, artifact, and oversensing related inappropriate ICD shock evaluation: ALTITUDE noise study. Pacing Clin Electrophysiol 2012; 35: 863-869.
13. Freedberg N, Feldman A,: Prognostic significance of implantable defibrillator shock: Are all shocks created equal? J Cardiovasc Electrophysiol 2012; 23: 741-743.
14. Varma N, Johnson M,: Prevalence of cancelled shock therapy and relationship to shock delivery in recipients of implantable cardioverter- defibrillators assessed by remote monitoring. Pacing Clin Electrophysiol 2009; 32 (Suppl 1): S42-S46.
15. Santini M, Gasparini M, Landolina M, Lunati M, Proclemer A, Padeletti L, Catanzariti D, Molon G, Botto G, La Rocca L, Grammatico A, Boriani G,: Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. J Am Coll Cardiol 2011; 57: 167-172.
16. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, Ricci R, Favale S, Zolezzi F, Di Belardino N, Molon G, Drago F, Villani G, Mazzini E, Vimercati M, Grammatico A,: Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005; 46: 1913-1920.
17. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD,: The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: The TRENDS study. Circ Arrhythm Electrophysiol 2009; 2: 474-480.
18. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH,: Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120-129.
19. Brachmann J, Böhm M, Rybak K, Klein G, Butter C, Klemm H, Schomburg R, Siebermair J, Israel C, Sinha A-M, Drexler H, Board obotOHSE, Investigators: Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: Rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). Eur J Heart Fail 2011; 13: 796-804.
20. Cowie MR, Sarkar S, Koehler J, Whellan DJ, Crossley GH, Tang WHW, Abraham WT, Sharma V, Santini M,: Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting. Eur Heart J 2013; 34: 2472-2480.
21. Varma N, Epstein AE, Irimpen A, Schweikert R, Love C, for the TRUST Investigators: Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial. Circulation 2010; 122: 325-332.
22. Crossley G, Boyle A, Vitense H, Chang Y, Mead R,: The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: The value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 2011; 57: 1181-1189.
23. Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A, Parati G, Borghi G, Zanaboni P, Valsecchi S, Marzegalli M,: Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: The evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 2012; 125: 2985-2992.
24. Guedon-Moreau L, Lacroix D, Sadoul N, Clementy J, Kouakam C, Hermida J-S, Aliot E, Boursier M, Bizeau O, Kacet S, for the ECOST trial Investigators: A randomized study of remote follow-up of implantable cardioverter defibrillators: Safety and efficacy report of the ECOST trial. Eur Heart J 2013; 34: 605-614.
25. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP,: Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: The ALTITUDE survival study. Circulation 2010; 122: 2359-2367.
26. Guedon-Moreau L, Kouakam C, Klug D, Lacroix D, Marquie C, Brigadeau F, Boule S, blangy H, Lacroix D, Sadoul N, Clementy J, Kacet S, for the ECOST trial Investigators: Decreased delivery of inapropriate shocks achieved by remote monitoring of ICD. A sub study of ECOST trial. J Cardiovasc Electrophysiol 2014; 25: 763-770.
27. Gilliam F, Hayes D, Boehmer J, Day J, Heidenreich P, Seth M, Jones P, Stein K, Saxon L,: Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: The ALTITUDE REDUCES study. J Cardiovasc Electrophysiol 2011; 22: 1023-1029.
28. Schwab J, Gasparini M, Lunati M, Proclemer A, Kaup B, Santi E, Ligorio G, Klersy C, DE Sousa J, Okreglicki A, Arenal A, Wijffels M, Lemke B,: Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: The ADVANCE III Trial. J Cardiovasc Electrophysiol 2009; 20: 663-666.
29. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, The Multicenter Automatic Defibrillator Implantation Trial I: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-1940.
30. Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JB, Hersi A, Gulaj M, Wijfels MC, Santi E, Manotta L, Arenal A,: Effect of long-detection interval vs standard-detection interval for implantable cardioverter- defibrillators on antitachycardia pacing and shock delivery: The advance III randomized clinical trial. J Am Med Assoc 2013; 309: 1903-1911.
31. Saeed M, Hanna I, Robotis D, Styperek R, Polosajian L, Khan A, Alonso J, Nabutovsky Y, Neason C,: Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: Results from the PROVIDE study. J Cardiovasc Electrophysiol 2014; 25: 52-59.
32. Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, Lombardo E, Regoli F, Biffi M, Burrone V, Denaro A, Boriani G,: A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: The RELEVANT role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD. study. Eur Heart J 2009; 30: 2758-2767.
33. Scott PA, Silberbauer J, McDonagh TA, Murgatroyd FD,: Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: A meta-analysis. Heart Rhythm 2014;doi: 10.1016/j.hrthm.2014.02.009. [Epub ahead of print].
34. Freedberg N, Hill J, Fogel R, Prystowsky E,: Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: Implications for antiarrhythmic therapy and driving restrictions. CARE Group. J Am Coll Cardiol 2001; 37: 1910-1915.
35. Al-Khatib S, Piccini J, Knight D, Stewart M, Clapp-Channing N, Sanders G,: Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: Results from a randomized pilot clinical trial. J Cardiovasc Electrophysiol 2010; 21: 545-550.
36. Dubner S, Auricchio A, Steinberg J, Vardas P, Stone P, Brugada J, Piotrowicz R, Hayes D, Kirchhof P, Breithardt G, Zareba W, Schuger C, Aktas M, Chudzik M, Mittal S, Varma N,: ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Ann Noninvasive Electrocardiol 2012; 17: 36-56.
37. Burri H, Senouf D,: Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators. Europace 2009; 11: 701-709.
38. Burri H, Heidbuchel H, Jung W, Brugada P,: Remote monitoring: A cost or an investment? Europace 2011; 13: ii44-48.
39. Vinck I, De Laet C, Stroobandt S, Van Brabandt H,: Legal and organizational aspects of remote cardiac monitoring: The example of implantable cardioverter defibrillators. Europace 2012; 14: 1230-1235.
40. Van der Velde ET, Atsma DE, Foeken H, Witteman TA, Hoekstra WH,: Remote monitoring of patients with implanted devices: Data exchange and integration. Eur J Prev Cardiol 2013; 20: 8-12.
41. Hernández-Madrid A, Lewalter T, Proclemer A, Pison L, Lip GYH, Blomstrom-Lundqvist C,: Remote monitoring of cardiac implantable electronic devices in Europe: Results of the European Heart Rhythm Association survey. Europace 2014; 16: 129-132.